Atossa Genetics
Arezoo Mirad has extensive experience in clinical development within the pharmaceutical and biotechnology industries. Currently serving as Senior Medical Director of Clinical Development at Atossa Therapeutics, Inc., Arezoo Mirad has held significant positions at Corcept Therapeutics, Alkermes, and Silicon DynamiX, where roles included Medical Director focusing on clinical development and oncology. Earlier in a career at the University of Colorado Denver, Arezoo Mirad contributed as Chief Research Assistant, demonstrating a strong foundation in research and clinical oversight.
This person is not in any teams
This person is not in any offices
Atossa Genetics
Atossa Genetics is a healthcare company developing cellular and molecular diagnostic risk assessment products for breast cancer patients.